Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2025 EC CMS139v13 Falls: Screening for Future Fall Risk
2022 EC CMS136v11 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2023 EC CMS136v12 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2025 EC CMS136v14 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2024 EC CMS136v13 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2025 EC CMS56v13 Functional Status Assessment for Total Hip Replacement
2024 EC CMS56v12 Functional Status Assessment for Total Hip Replacement
2022 EC CMS56v10 Functional Status Assessment for Total Hip Replacement
2023 EC CMS56v11 Functional Status Assessment for Total Hip Replacement
2022 EC CMS66v10 Functional Status Assessment for Total Knee Replacement
2025 EC CMS90v14 Functional Status Assessments for Heart Failure
2024 EC CMS90v13 Functional Status Assessments for Heart Failure
2022 EC CMS90v11 Functional Status Assessments for Heart Failure
2023 EC CMS90v12 Functional Status Assessments for Heart Failure
2022 EC CMS135v10 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 EC CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 EC CMS135v13 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 EC CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 EC CMS144v13 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 EC CMS144v12 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)